These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37652498)

  • 21. The relative biological effectiveness for carbon and oxygen ion beams using the raster-scanning technique in hepatocellular carcinoma cell lines.
    Habermehl D; Ilicic K; Dehne S; Rieken S; Orschiedt L; Brons S; Haberer T; Weber KJ; Debus J; Combs SE
    PLoS One; 2014; 9(12):e113591. PubMed ID: 25460352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary radiation measurements for particle therapy applications: prompt photons produced by
    Mattei I; Bini F; Collamati F; De Lucia E; Frallicciardi PM; Iarocci E; Mancini-Terracciano C; Marafini M; Muraro S; Paramatti R; Patera V; Piersanti L; Pinci D; Rucinski A; Russomando A; Sarti A; Sciubba A; Solfaroli Camillocci E; Toppi M; Traini G; Voena C; Battistoni G
    Phys Med Biol; 2017 Feb; 62(4):1438-1455. PubMed ID: 28114112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High Doses of Photons and Carbon Ions Comparably Increase Vascular Permeability in R3327-HI Prostate Tumors: A Dynamic Contrast-Enhanced MRI Study.
    Bendinger AL; Peschke P; Peter J; Debus J; Karger CP; Glowa C
    Radiat Res; 2020 Nov; 194(5):465-475. PubMed ID: 33045073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: the CLEOPATRA trial.
    Combs SE; Kieser M; Rieken S; Habermehl D; Jäkel O; Haberer T; Nikoghosyan A; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Sep; 10():478. PubMed ID: 20819220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of Photon and Carbon Ion Irradiation with Targeted Therapy Substances Temsirolimus and Gemcitabine in Hepatocellular Carcinoma Cell Lines.
    Dehne S; Fritz C; Rieken S; Baris D; Brons S; Haberer T; Debus J; Weber KJ; Schmid TE; Combs SE; Habermehl D
    Front Oncol; 2017; 7():35. PubMed ID: 28348976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The combined effect of fludarabine monophosphate and radiation as well as gemcitabine and radiation on squamous carcinoma tumor cell lines in vitro.
    Nitsche M; Christiansen H; Hermann RM; Lucke EM; Peters K; Rave-Frank M; Schmidberger H; Pradier O
    Int J Radiat Biol; 2008 Aug; 84(8):643-57. PubMed ID: 18661380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the effects of carbon ion and photon irradiation on the angiogenic response in human lung adenocarcinoma cells.
    Kamlah F; Hänze J; Arenz A; Seay U; Hasan D; Juricko J; Bischoff B; Gottschald OR; Fournier C; Taucher-Scholz G; Scholz M; Seeger W; Engenhart-Cabillic R; Rose F
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1541-9. PubMed ID: 21621345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Joint Optimization of Photon-Carbon Ion Treatments for Glioblastoma.
    Bennan ABA; Unkelbach J; Wahl N; Salome P; Bangert M
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):559-572. PubMed ID: 34058258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiation.
    Kitabayashi H; Shimada H; Yamada S; Yasuda S; Kamata T; Ando K; Tsujii H; Ochiai T
    Oncol Rep; 2006 Apr; 15(4):913-8. PubMed ID: 16525679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of different fiducial markers for image-guided radiotherapy and particle therapy.
    Habermehl D; Henkner K; Ecker S; Jäkel O; Debus J; Combs SE
    J Radiat Res; 2013 Jul; 54 Suppl 1(Suppl 1):i61-8. PubMed ID: 23824129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
    Combs SE; Burkholder I; Edler L; Rieken S; Habermehl D; Jäkel O; Haberer T; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Oct; 10():533. PubMed ID: 20925951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiosensitizing effect of carboplatin and paclitaxel to carbon-ion beam irradiation in the non-small-cell lung cancer cell line H460.
    Kubo N; Noda SE; Takahashi A; Yoshida Y; Oike T; Murata K; Musha A; Suzuki Y; Ohno T; Takahashi T; Nakano T
    J Radiat Res; 2015 Mar; 56(2):229-38. PubMed ID: 25599995
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential pattern of HIF-1α expression in HNSCC cancer stem cells after carbon ion or photon irradiation: one molecular explanation of the oxygen effect.
    Wozny AS; Lauret A; Battiston-Montagne P; Guy JB; Beuve M; Cunha M; Saintigny Y; Blond E; Magne N; Lalle P; Ardail D; Alphonse G; Rodriguez-Lafrasse C
    Br J Cancer; 2017 May; 116(10):1340-1349. PubMed ID: 28407653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a prospective randomized trial on long-term effectiveness of protons and carbon ions in prostate cancer: LEM I and α/β = 2 Gy overestimates the RBE.
    Eichkorn T; Karger CP; Brons S; Koerber SA; Mielke T; Haberer T; Debus J; Herfarth K
    Radiother Oncol; 2022 Aug; 173():223-230. PubMed ID: 35714806
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrinsic and extrinsic tumor characteristics are of minor relevance for the efficacy of split-dose carbon ion irradiation in three experimental prostate tumors.
    Glowa C; Peschke P; Brons S; Debus J; Karger CP
    Radiother Oncol; 2019 Apr; 133():120-124. PubMed ID: 30935567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial.
    Combs SE; Kieser M; Habermehl D; Weitz J; Jäger D; Fossati P; Orrechia R; Engenhart-Cabillic R; Pötter R; Dosanjh M; Jäkel O; Büchler MW; Debus J
    BMC Cancer; 2012 Apr; 12():137. PubMed ID: 22472035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare entities in head-and-neck cancer: salvage re-irradiation with carbon ions.
    Held T; Windisch P; Akbaba S; Lang K; Farnia B; Liermann J; Bernhardt D; Plinkert P; Freudlsperger C; Rieken S; Herfarth K; Debus J; Adeberg S
    Radiat Oncol; 2019 Nov; 14(1):202. PubMed ID: 31718670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.
    Wink KCJ; Roelofs E; Simone CB; Dechambre D; Santiago A; van der Stoep J; Dries W; Smits J; Avery S; Ammazzalorso F; Jansen N; Jelen U; Solberg T; de Ruysscher D; Troost EGC
    Radiother Oncol; 2018 Jul; 128(1):139-146. PubMed ID: 29545019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of human chordoma cell-kill for 290 MeV/n carbon ions versus 70 MeV protons in vitro.
    Fujisawa H; Genik PC; Kitamura H; Fujimori A; Uesaka M; Kato TA
    Radiat Oncol; 2013 Apr; 8():91. PubMed ID: 23587329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells.
    Zhang M; Boyer M; Rivory L; Hong A; Clarke S; Stevens G; Fife K
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):353-60. PubMed ID: 14751503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.